MBD5 and neurodevelopmental disorder: The utilization of CMA led to the identification of MBD5-associated neurodevelopmental disorder (MAND, MIM 156200), which is an ASD characterized by intellectual disability, motor delay, severe speech impairment, and behavioral problems5.